HTA225 A Review of External Evidence Used to Support Survival Extrapolation in Assessments of Cancer Drugs by the National Institute for Health and Care Excellence (NICE)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1683
https://www.valueinhealthjournal.com/article/S1098-3015(22)03888-8/fulltext
Title :
HTA225 A Review of External Evidence Used to Support Survival Extrapolation in Assessments of Cancer Drugs by the National Institute for Health and Care Excellence (NICE)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03888-8&doi=10.1016/j.jval.2022.09.1683
First page :
Section Title :
Open access? :
No
Section Order :
11239